Company Description
NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan.
The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing.
It also provides IVF treatment; surrogacy and ancillary caring services, including regular body check, as well as vitamins, supplements, and medicines to surrogate mothers; and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment.
The company offers its services through its clinics. NewGenIvf Group Limited was founded in 2010 and is based in Bangkok, Thailand.
| Country | Thailand |
| Founded | 2011 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 87 |
| CEO | Wing Fung Siu |
Contact Details
Address: PS Tower, 36/39-36/40, 13th Floor Bangkok, 10110 Thailand | |
| Phone | 66 2 116 9641 |
| Website | nivf.global |
Stock Details
| Ticker Symbol | NIVF |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001981662 |
| CUSIP Number | G0544E303 |
| ISIN Number | VGG0544E1473 |
| SIC Code | 8090 |
Key Executives
| Name | Position |
|---|---|
| Wing Fung Siu | Co-Founder, Chairman and Chief Executive Officer |
| Hei Yue Fong | Co-Founder, Chief Marketing Officer and Director |
| Ho Fai Chung | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 31, 2026 | 20-F | Annual and transition report of foreign private issuers |
| Mar 13, 2026 | EFFECT | Notice of Effectiveness |
| Mar 13, 2026 | 424B3 | Prospectus |
| Mar 11, 2026 | 6-K | Report of foreign issuer |
| Mar 2, 2026 | F-1 | Registration statement for certain foreign private issuers |
| Feb 4, 2026 | DRS | [Cover] Draft Registration Statement |
| Jan 20, 2026 | 6-K | Report of foreign issuer |
| Dec 2, 2025 | 6-K | Report of foreign issuer |
| Nov 25, 2025 | 6-K | Report of foreign issuer |
| Nov 10, 2025 | 6-K | Report of foreign issuer |